AU2001287578A1 - Substituted thienopyrimidine derivatives and the use thereof for the prophylaxisand therapy of cerebral ischaemia - Google Patents

Substituted thienopyrimidine derivatives and the use thereof for the prophylaxisand therapy of cerebral ischaemia

Info

Publication number
AU2001287578A1
AU2001287578A1 AU2001287578A AU8757801A AU2001287578A1 AU 2001287578 A1 AU2001287578 A1 AU 2001287578A1 AU 2001287578 A AU2001287578 A AU 2001287578A AU 8757801 A AU8757801 A AU 8757801A AU 2001287578 A1 AU2001287578 A1 AU 2001287578A1
Authority
AU
Australia
Prior art keywords
prophylaxisand
therapy
cerebral ischaemia
thienopyrimidine derivatives
substituted thienopyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001287578A
Inventor
Berthold Behl
Francisco Javier Garcia-Ladona
Kurt Schellhaas
Gerd Steiner
Laszlo Szabo
Liliane Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of AU2001287578A1 publication Critical patent/AU2001287578A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2001287578A 2000-07-03 2001-07-02 Substituted thienopyrimidine derivatives and the use thereof for the prophylaxisand therapy of cerebral ischaemia Abandoned AU2001287578A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10031389 2000-07-03
DE10031389A DE10031389A1 (en) 2000-07-03 2000-07-03 Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia
PCT/EP2001/007573 WO2002002569A1 (en) 2000-07-03 2001-07-02 Substituted thienopyrimidine derivatives and the use thereof for the prophylaxis and therapy of cerebral ischaemia

Publications (1)

Publication Number Publication Date
AU2001287578A1 true AU2001287578A1 (en) 2002-01-14

Family

ID=7647038

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001287578A Abandoned AU2001287578A1 (en) 2000-07-03 2001-07-02 Substituted thienopyrimidine derivatives and the use thereof for the prophylaxisand therapy of cerebral ischaemia

Country Status (4)

Country Link
AR (1) AR028775A1 (en)
AU (1) AU2001287578A1 (en)
DE (1) DE10031389A1 (en)
WO (1) WO2002002569A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101676728A (en) * 2002-04-19 2010-03-24 津莫吉尼蒂克斯公司 cytokine receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636769A1 (en) * 1996-09-10 1998-03-12 Basf Ag 3-Substituted pyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
DE19724980A1 (en) * 1997-06-13 1998-12-17 Basf Ag 3-Substituted 3,4-dihydro-thieno [2,3-d] pyrimidine derivatives, their preparation and use
DE19724979A1 (en) * 1997-06-13 1998-12-17 Basf Ag 3-Substituted pyrido [3,4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
US5960613A (en) * 1997-08-28 1999-10-05 Murray, Inc. Ride-on mower having bag-full indicator
DE19900545A1 (en) * 1999-01-11 2000-07-13 Basf Ag Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia
DE19900673A1 (en) * 1999-01-11 2000-07-13 Basf Ag Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders

Also Published As

Publication number Publication date
AR028775A1 (en) 2003-05-21
DE10031389A1 (en) 2002-01-17
WO2002002569A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2001269046A1 (en) Use of therapeutic benzamide derivatives
AU4458700A (en) Uses of phenylglycine derivatives
AU2002224808A1 (en) Use of thienopyrimidines
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
HUP0203961A3 (en) 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2001279709A1 (en) Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia
AU2001260834A1 (en) The treatment of herpes
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
SI1259515T1 (en) Thienopyridine derivatives and their use as anti-inflammatory agents
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
AU2001287578A1 (en) Substituted thienopyrimidine derivatives and the use thereof for the prophylaxisand therapy of cerebral ischaemia
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
PL350963A1 (en) Use of arylalkanoylpyridazines
AU2001225523A1 (en) Novel arylpropionaldehyde derivatives and production and use of the same
HK1053059A1 (en) New use of imidazotriazinon derivatives
AU2001268903A1 (en) Hexaglucal compound and the use and the methods of preparing them
HUP0202614A3 (en) Use of thienopyrimidines
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
AU2001276556A1 (en) Novel pharmaceutical use of quinnoline derivatives
AU2001261785A1 (en) Vdup1 promoter and methods of use thereof